Efficacy and safety of first line afatinib treatment for patients with stage IV lung adenocarcinoma
Latest Information Update: 14 Nov 2017
Price :
$35 *
At a glance
- Drugs Afatinib (Primary)
- Indications Lung cancer
- Focus Adverse reactions; Therapeutic Use
- 14 Nov 2017 New trial record